Provexis (LON:PXS) Announces Quarterly Earnings Results

Provexis (LON:PXS – Get Free Report) posted its quarterly earnings results on Thursday. The company reported GBX (0.02) EPS for the quarter, Digital Look Earnings reports. Provexis had a negative return on equity of 49.45% and a negative net margin of 69.30%.

Provexis Trading Up 1.6%

Provexis stock traded up GBX 0.01 during midday trading on Thursday, reaching GBX 0.94. The stock had a trading volume of 580,714 shares, compared to its average volume of 1,962,177. The company has a fifty day moving average price of GBX 1.05 and a two-hundred day moving average price of GBX 1.07. Provexis has a 12 month low of GBX 0.55 and a 12 month high of GBX 1.55. The company has a market capitalization of £22.05 million, a P/E ratio of -47.00 and a beta of 0.66.

Get Provexis alerts:

About Provexis

(Get Free Report)

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function.

See Also

• Five stocks we like better than Provexis
• Everyone in AI Is Quietly Copying Palantir’s Playbook
• Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
• JPMorgan Bets on Genius Sports as the Market Loses Patience
• Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question

Receive News & Ratings for Provexis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provexis and related companies with MarketBeat.com's FREE daily email newsletter.